VANDA PHARMACEUTICALS INC (VNDA)
US9216591084 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 268.7M 8.26% | 254.4M -5.32% | 192.64M -24.28% | 203.43M 5.60% | 290.6M 42.85% | 336.3M 15.73% | 295.8M -12.04% | 245.82M -16.90% | 215.22M -12.45% | 197.88M -8.06% | |
| EBITDA YoY % growth | 64.9M 75.41% | 9M -86.13% | -10.942M -221.58% | -20.604M -88.30% | -38.046M -84.65% | 12.138M 131.90% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | 62M 81.82% | 6.3M -89.84% | -13.952M -321.46% | -41.153M -194.96% | -1.829M 95.56% | 46.349M 2,633.84% | 20.4M -55.99% | -25.5M -225.00% | -43.86M -72.00% | -64.26M -46.51% | |
| Operating Margin | 23.07% | 2.48% | -7.24% | -20.23% | -0.63% | 13.78% | 6.90% | -10.37% | -20.38% | -32.47% | |
| EPS YoY % growth | 0.58 34.88% | 0.12 -79.31% | 0.05 -58.33% | -0.33 -752.80% | 0.21 163.54% | 1.03 396.73% | N/A | N/A | N/A | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.11 -172.01% | -0.01 80.58% | 0.03 138.25% | 0.09 198.23% | 0.11 196.87% |
| Revenue Q2Q % growth | 53.293M 17.72% | 62.243M 31.15% | 68.796M 36.30% | 77.021M 61.64% | 82.541M 54.88% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -11.794M -66.25% | -1.918M 79.23% | 2.69M 126.51% | 8.345M 175.86% | 11.552M 197.95% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.09 | -0.17 | 0.08 | 45.98% |
| Q2 2024 Q2Q % growth | -0.08 -366.67% | -0.21 | 0.13 | 62.65% |
| Q1 2024 Q2Q % growth | -0.07 -216.67% | 0.05 | -0.12 | -237.25% |
| Q4 2023 Q2Q % growth | -0.04 -133.33% | -0.09 | 0.05 | 56.43% |
| Q3 2023 Q2Q % growth | 0.00 -100.00% | -0.04 | 0.04 | 100.00% |
| Q2 2023 Q2Q % growth | 0.03 -40.00% | -0.13 | 0.16 | 122.62% |
| Q1 2023 Q2Q % growth | 0.06 154.55% | % | ||
| Q4 2022 Q2Q % growth | 0.12 | 0.08 | 0.04 | 47.06% |
| Q3 2022 Q2Q % growth | 0.06 -57.14% | 0.09 | -0.03 | -34.64% |
| Q2 2022 Q2Q % growth | 0.05 -70.59% | 0.14 | -0.09 | -64.99% |
| Q1 2022 Q2Q % growth | -0.11 -173.33% | -0.01 | -0.10 | -978.43% |
| Q4 2021 Q2Q % growth | 0.12 -20.00% | 0.09 | 0.03 | 38.41% |
| Q3 2021 Q2Q % growth | 0.14 27.27% | 0.18 | -0.04 | -23.75% |
| Q2 2021 Q2Q % growth | 0.17 6.25% | 0.14 | 0.03 | 19.05% |
| Q1 2021 Q2Q % growth | 0.15 1,400.00% | 0.15 | 0.00 | -1.96% |
| Q4 2020 Q2Q % growth | 0.15 87.50% | 0.14 | 0.01 | 8.13% |
| Q3 2020 Q2Q % growth | 0.11 -50.00% | 0.10 | 0.01 | 13.13% |
| Q2 2020 Q2Q % growth | 0.16 -23.81% | 0.04 | 0.12 | 259.20% |
| Q1 2020 Q2Q % growth | 0.01 200.00% | 0.00 | 0.01 | 460.22% |
| Q4 2019 Q2Q % growth | 0.08 -57.89% | 0.12 | -0.04 | -30.59% |
| Q3 2019 Q2Q % growth | 0.22 69.23% | 0.07 | 0.15 | 196.48% |
| Q2 2019 Q2Q % growth | 0.21 133.33% | 0.00 | 0.21 | 4,579.14% |
| Q1 2019 Q2Q % growth | -0.01 -116.67% | 0.07 | -0.08 | -115.13% |
| Q4 2018 Q2Q % growth | 0.19 | 0.01 | 0.18 | 1,800.76% |
| Q3 2018 Q2Q % growth | 0.13 | -0.03 | 0.16 | 539.49% |
| Q2 2018 Q2Q % growth | 0.09 | -0.19 | 0.28 | 148.13% |
| Q1 2018 Q2Q % growth | 0.06 | -0.17 | 0.23 | 134.60% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 47.651M 22.76% | 50.138M | -2.487M | -4.96% |
| Q2 2024 Q2Q % growth | 50.474M 9.59% | 48.817M | 1.657M | 3.39% |
| Q1 2024 Q2Q % growth | 47.46M -24.06% | 49.47M | -2.01M | -4.06% |
| Q4 2023 Q2Q % growth | 45.271M -29.79% | 37.74M | 7.531M | 19.95% |
| Q3 2023 Q2Q % growth | 38.815M -40.58% | 45.39M | -6.575M | -14.49% |
| Q2 2023 Q2Q % growth | 46.056M -28.47% | 49.98M | -3.924M | -7.85% |
| Q1 2023 Q2Q % growth | 62.5M 3.84% | % | ||
| Q4 2022 Q2Q % growth | 64.48M -5.20% | 68.952M | -4.472M | -6.49% |
| Q3 2022 Q2Q % growth | 65.32M -6.82% | 72.42M | -7.1M | -9.80% |
| Q2 2022 Q2Q % growth | 64.39M -5.17% | 68.34M | -3.95M | -5.78% |
| Q1 2022 Q2Q % growth | 60.19M -3.96% | 59.16M | 1.03M | 1.74% |
| Q4 2021 Q2Q % growth | 68.02M 0.55% | 71.441M | -3.421M | -4.79% |
| Q3 2021 Q2Q % growth | 70.1M 16.23% | 75.735M | -5.635M | -7.44% |
| Q2 2021 Q2Q % growth | 67.9M 9.15% | 71.145M | -3.245M | -4.56% |
| Q1 2021 Q2Q % growth | 62.67M 8.05% | 69.87M | -7.2M | -10.30% |
| Q4 2020 Q2Q % growth | 67.65M 11.03% | 65.28M | 2.37M | 3.63% |
| Q3 2020 Q2Q % growth | 60.31M 1.38% | 65.229M | -4.919M | -7.54% |
| Q2 2020 Q2Q % growth | 62.21M 5.33% | 63.189M | -979K | -1.55% |
| Q1 2020 Q2Q % growth | 58M 21.57% | 58.004M | -4K | -0.01% |
| Q4 2019 Q2Q % growth | 60.93M 14.88% | 60.767M | 163K | 0.27% |
| Q3 2019 Q2Q % growth | 59.49M 21.06% | 59.492M | -2K | 0.00% |
| Q2 2019 Q2Q % growth | 59.06M 24.73% | 55.229M | 3.831M | 6.94% |
| Q1 2019 Q2Q % growth | 47.71M 9.45% | 52.775M | -5.065M | -9.60% |
| Q4 2018 Q2Q % growth | 53.04M | 52.591M | 449K | 0.85% |
| Q3 2018 Q2Q % growth | 49.14M | 50.429M | -1.289M | -2.56% |
| Q2 2018 Q2Q % growth | 47.35M | 48.221M | -871K | -1.81% |
| Q1 2018 Q2Q % growth | 43.59M | 42.371M | 1.219M | 2.88% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -6.67% | 9.43% | 34.69% |
| Revenue | 0% | 3.46% | 0.44% | -1.03% |